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Retention of Effect
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and Paula Bourke 1,3*
1 Plasma Research Group, School of Food Science and Environmental Health, Technological University Dublin, Dublin,
Ireland, 2 TheraDep, Questum Centre, Clonmel, Ireland, 3 School of Biological Sciences, Queens University Belfast, Belfast,
United Kingdom
Antimicrobial coating of medical devices has emerged as a potentially effective tool
to prevent or ameliorate device-related infections. In this study the plasma deposition
process for direct deposition of pharmaceutical drugs on to a range of surfaces
and the retention of structure function relationship and antimicrobial efficacy against
mono-species biofilms were investigated. Two selected sample antibiotics—ampicillin
and gentamicin, were deposited onto two types of surfaces—polystyrene microtiter
plates and stainless steel coupons. The antimicrobial efficacy of the antibiotic-coated
surfaces was tested against challenge populations of both planktonic and sessile
Escherichia coli and Pseudomonas aeruginosa, with responses monitored for up to
14 days. The plasma deposition process bonded the antibiotic to the surfaces, with
localized retention of antibiotic activity. The antibiotics deposited on the test surfaces
retained a good efficacy against planktonic cells, and importantly prevented biofilm
formation of attached cells for up to 96 h. The antibiotic rapidly eluted from the surface
of antibiotic-coated surfaces to the surrounding medium, with retention of effect in
this surrounding milieu for up to 2 weeks. Control experiments established that there
was no independent antimicrobial or growth promoting effect of the plasma deposition
process, where there was no antibiotic in the helium plasma assisted delivery stream.
Apart from the flexibility offered through deposition on material surfaces, there was no
additive or destructive effect associated with the helium assisted plasma deposition
process on the antibiotic. The plasma assisted process was a viable mean of coating
clinically relevant materials and developing innovative functional materials with retention of
antibiotic activity, without employing a linker or plasma modified polymer, thus minimizing
bio-compatibility issues for medical device materials. This offers potential to prevent
or control instrumented or non-permanent device associated infection localized to the
surgical or implant site.
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INTRODUCTION
Medical device-associated infections caused by antibiotic-
resistant pathogens are a global public health concern driving
research toward new antibiotics, antibiotic alternatives, and
mechanisms to reinstate antibiotic activity. Such infections
are generally caused by microorganisms that form biofilms
on various devices including orthopedic implants, central
venous catheters, and urinary catheters (Buhmann et al.,
2016). The microorganisms frequently associated with medical-
device related infections include both Gram-positive bacteria,
such as Staphylococcus aureus, Staphylococcus epidermidis,
and Enterococcus faecalis, and Gram-negative bacteria
(Percival et al., 2015)—most frequently Escherichia coli and
Pseudomonas aeruginosa. E. coli was one of the first causes of
orthopedic implant infections (Crémet et al., 2015), whereas the
opportunistic pathogen P. aeruginosa is a frequent gram-negative
etiologic agent associated with infections of indwelling catheters
and foreign body implants (Brouqui et al., 1995). Pseudomonas
aeruginosa is often associated with chronic biofilm infections and
it has become a model organism for biofilm research (Harmsen
et al., 2010; Christensen et al., 2013).
The consequences of implant-associated infections are
significant and in most cases require revision surgery, with
removal of the implant and prolonged antibiotic treatment
(Ketonis et al., 2012). Molecular antibiotics traditionally used
against bacteria face several disadvantages, including the
worldwide emergence of antibiotic resistance, difficulty of
incorporation into many materials and sensitivity to harsh
environments encountered during industrial processes (Levy and
Marshall, 2004), therefore, new approaches of drug delivery are
under investigation. The main methods to decrease incidence
of device-related infections include anti-adhesive biomaterials
using physicochemical surface modification methods, e.g., non-
drug containing coatings, films and ion treatments, or, direct
incorporation of active compound into or onto the medical
device (Wu and Grainger, 2006). The purpose of these bioactive
surfaces is to disrupt the metabolic activity of the microbes or to
prevent bacterial adhesion to the implant and, consequently, to
inhibit the development of biofilm (Ketonis et al., 2012). Wu and
Grainger (2006) list benefits of local drug release strategies over
systemic drug therapy as: lower doses of antimicrobial agents
needed for treatment, extended period of controlled release from
surfaces of devices directly to site, lack of systemic drug exposure,
as well as less likelihood of promoting antibiotic resistance.
An emerging approach for drug delivery is cold plasma
technology, which is widely employed for materials surface
modifications. In contrast to “wet” chemistry methods which
depend strongly on substrate properties, plasma deposition of
antimicrobial coatings can be applied to a broad range of
polymers, ceramics, and metal surfaces (Nikiforov et al., 2016)
and the coating may be adhered to the surface without the use of
linkers, binders, or polymers that may impact biocompatibility.
In this study, the effect of a cold plasma deposition process
on antibiotics was determined, examining the impact on the
antibiotic functional properties, specifically the retention of
antimicrobial activity, the retention of efficacy, comparison with
controls, and evaluation of elution from the antibiotic coated
surface. Ampicillin and gentamicin were selected and deposited
onto two types of surfaces—polystyrene microtiter plates and
stainless steel coupons. Although safety of local administration
of gentamicin has been debated and tested in recent studies,
this antibiotic was incorporated in the present study as it has
been widely used in medicinal applications over the past 50
years and due to its wide spectrum of bactericidal activity against
both gram-negative and gram-positive organisms, including
staphylococci (Chen et al., 2014). The efficacy of antibiotic-coated
surfaces was tested against both E. coli and P. aeruginosa.
MATERIALS AND METHODS
Bacterial Strains and Inocula Preparation
Escherichia coliATCC 25922 and P. aeruginosaATCC 27853 were
obtained from the microbiology stock culture of the School of
Food Science and Environmental Health of the Dublin Institute
of Technology. Stock cultures in the form of protective beads
were maintained at −70◦C and working inoculum was prepared
as described previously (Los et al., 2017). Briefly, one protective
bead of culture of E. coli and P. aeruginosa was streaked onto
separate tryptic soy agar (TSA, Biokar Diagnostics, France) plate
and incubated at 37◦C for 24 h. A single isolated colony of either
E. coli or P. aeruginosa was inoculated into Mueller Hinton
Broth (MHB, Oxoid LTD, UK) and incubated overnight at 37◦C.
Suspensions were washed twice in phosphate-buffered saline
(PBS, Sigma-Aldrich Co., Ireland) and bacterial suspensions (6–
7 log CFU/ml) in either MHB or PBS were prepared using
0.5 McFarland standard (BioMerieux, Marcy-l’Etoile, France).
Inoculum concentration was confirmed by plating appropriate
dilutions on TSA and incubation at 37◦C for 24 h.
Biofilm Formation
The effect of deposited antibiotic on 24 h bacterial monoculture
biofilms was investigated. Biofilms were formed by adding 200
µl of prepared bacterial suspension (7 log CFU/ml) of either
E. coli or P. aeruginosa into the wells of a 96-well flat bottom
microtiter plate (Sarstedt, Nümbrecht, Germany). Plates were
incubated at 37◦C for 24 h and after that the supernatant
containing suspended planktonic cells was removed. Plates were
washed gently twice with PBS to remove any planktonic cells
(Los et al., 2017).
Preparation of Stock and Working
Solutions of Antibiotics
Stock solutions of ampicillin and gentamicin (Sigma-Aldrich,
Ireland) were prepared using sterile deionized water and further
stored at 4◦C. Powder antibiotics were stored in the temperature
indicated by the drug manufacturer. For antibiotic susceptibility
tests of planktonic cells and bacterial biofilms, stock solutions
were diluted inMHB to obtain working solutions two times more
concentrated than the final highest drug concentration used in
the experiment (Table 1). For plasma deposition on microtiter
plates and steel coupons, antibiotic solutions (concentration−50
mg/ml) were prepared using sterile deionized water.
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Antibiotic Susceptibility of Planktonic Cells
and Biofilms
Minimum inhibitory concentration (MIC) and the effects
on biofilm formation in the presence of antibiotics were
determined. Concentration ranges used for each antibiotic and
microorganism are listed in Table 1. For determination of MIC,
broth micro-dilution method for antibacterial testing was used as
recommended by the Clinical and Laboratory Standards Institute
protocol (CLSI, 2012). The assay was performed according to
the protocol of Sarker et al. (2007) with minor modifications.
A concentration gradient of antibiotic was created in 96-well
flat bottom microtiter plates (Sarstedt, Nümbrecht, Germany)
−100 µl of antibiotic in MHB in concentration two times higher
than the highest concentration used in the experiment was added
into the wells in the first row, while 50 µl of MHB with no
antibiotic was added into the remaining wells. Serial dilutions
were performed by pipetting 50µl of antibiotic solution from row
to row in decreasing concentrations. Finally, 50 µl of bacterial
suspension (6 log CFU/ml) of either E. coli or P. aeruginosa were
inoculated into each well to achieve a final cell concentration of 5
× 105 CFU/ml. Additionally, plates included a negative control
(MHB only) and a positive bacterial growth control. Plates
were incubated for 24 h at 37◦C. Bacterial growth curves in the
presence of antibiotic were determined spectrophotometrically
TABLE 1 | Concentration ranges of antibiotics used in the study.
Antibiotic MIC (µg/ml) Biofilm testing (µg/ml)
E. coli P. aeruginosa E. coli P. aeruginosa
Ampicillin 0.25–128 NA 8–256 NA
Gentamicin 0.031–16 0.031–16 2–64 1–32
NA, not applicable.
using optical density at 600 nm. TheMIC value was defined as the
lowest antibiotic concentration that caused no bacterial growth.
To determine the effect of antibiotic concentration range on
biofilm formation, antibiotic solutions (Table 1) diluted in MHB
were added into the wells containing preformed biofilms. Plates
were further incubated at 37◦C for 72 h (total incubation time
−96 h). The supernatant was removed, plates were washed gently
twice with PBS and biofilms air-dried for further analysis.
Effect of Antibiotic-Coated Surfaces on
Microbial Growth
Plasma Deposition of Antibiotics on Microtiter Plates
and Steel Coupons
Plasma deposition was carried out using a purpose build
deposition system comprising a Redline G2000 High Voltage
power supply connected to a custom build Teflon deposition unit
encasing two metal electrodes. a pneumatic nebulizer (T2100,
Burgener Research) was placed between the electrodes and this
was connected to a syringe pump to provide a constant flow of
gentamicin sulfate aqueous solution (50 mg/ml). The liquid was
nebulized using a helium flow of ∼3 slm. In addition, a separate
helium flow of 8 slm was provided to the metal electrodes to
create the plasma discharge. The plasma discharge was combined
with the nebulized droplet spray in an acrylic tube (18mm inner
diameter × 35mm length) and the substrates to be coated were
placed at the outlet of the tube. This is shown schematically
in Figure 1. For larger areas or multiple smaller coupons, the
plasma was mounted on a computer numerically controlled table
and moved in a raster pattern over the target surface as shown
in Figure 2. Different antibiotic concentrations on the surface
were obtained by coating the plates with 1, 3, and 5 layers of each
antibiotic. Steel coupons were coated with 18 layers of gentamicin
(9 layers on each side of the coupon). After plasma-deposition,
both microtiter plates and steel coupons were stored at 4◦C.
FIGURE 1 | Plasma deposition system.
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FIGURE 2 | Plasma assisted deposition on (A) 96-well microtiter plates, (B) steel coupons.
TABLE 2 | Tests with solutions containing gentamicin released from the plasma deposited steel coupon into PBS and MHB.
Suspension Planktonic cells Biofilm testing
Coupons in PBS Coupons in MHB Coupons in PBS Coupons in MHB
Bacterial suspension in PBS 50 µl 50 µl – –
Antibiotic solution 75 µl (PBS-G) 75 µl (MHB-G) 75 µl (PBS-G) 75 µl (MHB-G)
Other 75 µl MHB 75 µl PBS 75 µl MHB 125 µl PBS
50 µl PBS
Total volume in each well 200 µl 200 µl 200 µl 200 µl
PBS-G, solution containing gentamicin released from the steel coupon into PBS; MHB-G, MHB solution containing gentamicin released from the steel coupon into MHB.
Bacterial Growth and Biofilm Formation on
Antibiotic-Coated Microtiter Plates
Two hundred microliter of prepared bacterial suspension (7 log
CFU/ml) of either E. coli or P. aeruginosa in MHB were added
into the wells of plasma-treated plates with no active component
and antibiotic plasma-coated plates to consider if the plasma
coating process had any additional antimicrobial or growth
promoting effect, bacterial growth on untreated plates was also
tested. Plates were incubated at 37◦C for 24 h and the growth of
planktonic cells wasmonitored via optical densitymeasurements.
In a separate set of experiments, plates were incubated at the
same temperature for 96 h—after this time, biofilm formation
on the plates was monitored using crystal violet, XTT and plate
count assays.
Antimicrobial Efficacy of Gentamicin-Coated Steel
Coupons
Blank plasma-treated steel coupons (control) or gentamicin
plasma-coated coupons (ACP-G) were transferred into separate
sterile tubes containing 10ml of bacterial suspension (7 log
CFU/ml) in either PBS or MHB. Suspensions were further
incubated up to 24 h at 37◦C. Surviving populations of cells were
assessed at 0, 1, 2, 4, 6, and 24 h of incubation by withdrawing
0.1ml and 1ml of cell suspension from the tube followed by
plating appropriate dilutions on TSA. Growth of planktonic cells
in the presence of plasma-treated and gentamicin-plasma coated
steel coupons was compared to controls with no coupons.
Elution Tests and Stability of Gentamicin-Coated
Steel Coupons During dry Storage
The detachment of gentamicin from steel coupons, elution into
liquid supernatant and antibiotic stability was assessed over a
period of 14 days. Coupons were submerged in tubes containing
10ml of either a buffer solution (PBS) or nutrient rich medium
(MHB) (1 coupon per tube) and incubated at 37◦C up to 14
days. At each of 7 time points (days: 0, 1, 2, 4, 7, 10, and
14), two coupons from two randomly selected separate tubes
were removed and antimicrobial efficacy of the solutions against
planktonic cells and biofilms was tested. The final volume of
antibiotic eluate in both PBS and MHB solutions was 37.5% (v/v)
of the total test volume (Table 2).
To quantify the effect of these antibiotic solutions in either
PBS or MHB on planktonic cells, 2-fold dilutions were prepared
on the plates as previously described MIC procedure. Serial
dilutions were performed by pipetting 75µl of antibiotic solution
from row to row in serially decreasing concentrations (volume
of antibiotic suspension in first row −150 µl). To obtain the
same amount of nutrient rich medium (MHB) in each well,
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solutions containing gentamicin released from the steel coupons
into PBS were filled with 75 µl of MHB, whereas gentamicin-
containing MHB solutions were supplemented with 75 µl of
PBS (Table 2). Finally, 50 µl of bacterial suspensions in PBS
(2 × 106 CFU/ml) of either E. coli or P. aeruginosa were
inoculated into each well to achieve a final cell concentration
of 5 × 105 CFU/ml. Plates were incubated at 37◦C for 24 h
and the growth of planktonic cells was monitored via optical
density measurements. Additionally, to provide an insight into
the stability of antibiotic coating, antimicrobial efficacy of the
solutions containing antibiotic released from the coupons against
planktonic cells was investigated for coupons stored for 3 weeks
at 4◦C (assessed immediately after placing coupon into the
liquid—day 0).
The effect of the released antibiotic solutions in either PBS
or MHB on bacterial biofilms was also quantified. Twenty
hours biofilms were prepared as described in section Antibiotic
susceptibility of planktonic cells and biofilms. Antibiotic
solutions were added into the wells containing biofilms.
Subsequently, the wells were filled with either PBS or MHB
to obtain the same amount of MHB in each well (Table 1).
Plates were further incubated at 37◦C for 72 h (total incubation
time −96 h). Finally, the supernatant was removed, plates were
washed gently twice with PBS and biofilms air-dried were
further analyzed.
Calculation of Gentamicin Deposition Concentration
The starting solution was 50 mg/ml gentamicin in sterile water.
The flow rate for the deposition was 45 ul/min, resulting in
2.25mg entering the system per minute (0.045 ml/min ∗ 50
mg/ml). The coating time for the platform has been established
as 245 s. The platform size was 0.085m ∗ 0.125m = 106.25
cm2. Using the time required to coat the platform and the
concentration entering the system at a defined flow rate, the
concentration per layer was 9.18mg. Taking 9.18mg per 106.25
cm2, this yields 0.0864 mg/cm2. The system efficiency has
been previously calculated at 30–40%, thus yielding a range of
0.02592–0.03456 mg/cm2. For a 10mm coupon; pi r2 = pi 0.005
m2 = 0.7854 cm2. At 30% efficiency: 0.7854 cm2 ∗ 0.02592mg
= 0.0204mg per coupon, per layer, and at 40% efficiency:
0.7854 cm2 ∗ 0.03456mg = 0.0271mg per coupon, per layer.
Applying nine layers per coupon side yielded 0.3672–0.4878mg
of gentamicin per coupon.
Microbiological Analysis
Optical Density Measurements
Growth of planktonic cells and bacterial survivability in presence
of antibiotics was monitored by optical density (600 nm)
measurements using a micro-plate reader (Synergy HT, Biotek
Instruments Inc.) during 24 h of incubation.
Crystal Violet Assay
The crystal violet (CV) assay was used for the quantification of
bacterial biomass and was performed according to the procedure
described in Peeters et al. (2008) with minor modifications.
For fixation of the biofilms, 100 µl of 99% methanol was
added (15min), after which supernatants were removed and
the plates were air-dried. Then, 100 µl of a 0.2% CV solution
(Merck, Portugal) was added to all wells. After 20min, the
excess free CV was removed by rinsing the plates. Finally, bound
CV was released by adding 150 µl of 33% acetic acid (Sigma
Aldrich, Ireland). The absorbance was measured at 590 nm
using a microplate reader. All steps were carried out at room
temperature. Each absorbance value was corrected by subtracting
the means of absorbance of a blank (uninoculated medium).
XTT Assay
The XTT assay was used to quantify metabolic activity and was
carried out according to the procedure described in Peeters
et al. (2008). Before each assay, fresh solutions of 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-
2H-tetrazolium hydroxide (XTT, 1 mg/ml, Sigma-Aldrich
Co., Ireland) were prepared by dissolving 4mg in 10ml of
pre-warmed PBS. The solution was supplemented with 5.5mg
menadione (Sigma-Aldrich Co., Ireland) in 10ml acetone
(Sigma-Aldrich Co., Ireland). The wells containing biofilms
and negative controls (media without inocula) were filled
with sterile PBS (100 µl) and then XTT-menadione (100 µl)
was added. Plates were incubated for 5 h at 37◦C in the dark.
After incubation, the supernatant (100 µl) from each well was
transferred into the wells of a new 96-well microtiter plate and
the absorbance at 486 nm was measured. Each absorbance value
was corrected by subtracting the means of absorbance of a blank
(uninoculated medium).
Contact Angle Measurements
To investigate the changes of surface characteristics of steel
coupons after plasma deposition, the apparent contact angles of
deionized water (Sigma Aldrich, Ireland) on the steel samples
weremeasured by the sessile drop technique using a contact angle
meter (Theta Lite Optical Tensiometer, Biolin Scientific, UK).
Analysis was performed immediately after deposition of a single
droplet on the coupon surface. The images were recorded at 15
frames per second for 10 s and analyzed using the OneAttension
software (v 2.1). All the values reported are the mean of more
than 100 data points done in triplicates. The contact angle
measurements from within the wells of the 96 well microplates
were conducted using a Kruss TVA100 top view analyzer. The
analysis used a 0.5 µl drop of deionized water and measurements
were recorded 60 s after placing the drop in the well. All analysis
was conducted with the Kruss ADVANCE software package.
Fourier Transform Infra-Red (FTIR)
Spectroscopy
FTIR spectroscopy was carried out by applying the gentamicin
sulfate coatings directly onto NaCl discs. For the non-plasma
deposited sample, the solution was sprayed at a flow rate of 45
µL/min for 60 s and then allowed to dry in air. Plasma deposition
was carried out as described in section Plasma deposition of
antibiotics on microtiter plates and steel coupons using NaCl
discs as the substrate with a static deposition time of 60 s. FTIR
spectra were then collected on a Perkin Elmer Spectrum 2000
instrument operating in single beam mode using 64 scans and
a 0.5 cm−1 resolution.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 December 2019 | Volume 9 | Article 428
Los et al. Cold Plasma Localized Delivery of Antibiotics
TABLE 3 | The MIC values of selected antibiotics tested against E. coli and P.
aeruginosa.
Antibiotic E. coli P. aeruginosa
MIC (µg/ml) Interpretation MIC (µg/ml) Interpretation
Ampicillin 8 S NA NA
Gentamicin 2 S 4 S
S, susceptible; NA, not applicable.
Statistical Analysis
Statistical analysis was performed by analysis of variance
(ANOVA) using IBM SPSS statistics 25 Software
(SPSS Inc., Chicago, USA) according to the method
of Fisher’s Least Significant Difference-LSD at the
0.05 level.
RESULTS
Sensitivity of E. coli and P. aeruginosa to
Selected Antibiotics—Planktonic
Susceptibility Testing and the Effect of
Antibiotics on Biofilm Formation
The susceptibility of E. coli and P. aeruginosa to selected
antibiotics was confirmed to benchmark the antibiotic
effects. The MIC values are presented in Table 3. The
interpretation of the MIC values was based on the Clinical
and Laboratory Standards Institute (CLSI) guidelines published
in annual supplement Performance Standards for Antimicrobial
Susceptibility Testing (M100-S28) (CLSIC and LSI, 2018).
The effect of selected antibiotics against 24-h-old biofilms
is shown in Figure 3, with total biofilm biomass and metabolic
activity assessed by crystal violet (CV) and XTT assays,
respectively. In general, biofilm challenges are less susceptible
to antibiotics than planktonic cells of bacteria (Hall and Mah,
2017). In the case of E. coli biofilms exposed to gentamicin,
a concentration of 8µg/ml and above significantly decreased
biomass production, whereas all tested concentrations (2–
64µg/ml) negatively affected bacterial metabolic activity
(Figure 3A). Lower concentrations of ampicillin (8 and
16µg/ml) enhanced biomass production of E. coli, whereas
concentrations of 32µg/ml and above caused a significant
decrease of metabolic activity within E. coli biofilms, but did
not affect biomass (Figure 3B). This phenomenon is not unique
to ampicillin - it has been widely reported in literature that
sublethal concentrations of antibiotics can cause metabolic and
physiological changes indicating that the organism is preparing
to withstand lethal antibiotic concentrations, which can lead to
e.g., stimulation of biofilm formation at lower doses of antibiotics
(Nguyen et al., 2014; Knudsen et al., 2016). For P. aeruginosa
biofilms treated with gentamicin, similar trends were observed
for both CV and XTT assays—a concentration of 4µg/ml and
above significantly decreased biomass production and metabolic
activity (Figure 3C).
FIGURE 3 | Effect of antibiotic concentration on bacterial biofilm formation.
(A,B) Biofilms formed by E. coli in presence of ampicillin and gentamicin,
respectively. (C) Biofilms formed by Pseudomonas aeruginosa in presence
of gentamicin. * indicates a significant difference between the corresponding
untreated control and samples treated with antibiotics (p < 0.05).
Effect of Plasma Coating Process With No
Active Component
To determine if plasma coating itself had any antimicrobial
or growth promotion effect, plasma treatment was applied to
two types of surfaces—microtiter plates and steel coupons, with
no active component included in the nebulizer stream. No
significant differences were recorded between the growth on
untreated or plasma-treated microtiter plates, monitored via
optical density measurements over 24 h. Similarly, the planktonic
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growth of E. coli and P. aeruginosa was not significantly affected
in the presence of plasma-treated coupons as compared to
controls with no coupons (data not shown).
Effect of Plasma Coating Surfaces With
Antibiotic on Microbial Growth
Microtiter Plates
The next stage of analysis was performed using microtiter plates
coated with ampicillin and gentamicin. The effect of plasma
deposited antibiotics on planktonic growth and subsequently
on biofilm formation and viability of the two challenge
microorganisms—E. coli and P. aeruginosa, was investigated.
Growth of E. coli was tested using plates coated with either
ampicillin or gentamicin, whereas growth of P. aeruginosa—with
gentamicin only. Multiple deposition layers of antibiotics (1, 3,
and 5) on the plates were compared.
No growth of planktonic cells of E. coliwas recorded after 24 h
of incubation in plates coated with either ampicillin (Figure 4A)
or gentamicin (Figure 4B). Similarly, gentamicin deposited onto
plates completely inhibited growth of P. aeruginosa (Figure 4C).
In all cases, one layer of an antibiotic was sufficient to
prevent bacterial growth. As quantifying the exact amount of
antibiotic deposited on a microtiter plate was not possible,
antimicrobial efficacy of the antibiotics deposited on the plates
were compared to calibration curves to provide an indication of
the concentration range of functional antibiotic deposited during
the process.
Plasma deposited antibiotics significantly inhibited bacterial
biofilm formation on microtiter plates (Figure 5). On plates
coated with ampicillin no biomass production was recorded
for E. coli, and metabolic activity was lower than 2% of that
observed for controls. Regardless of the number of layers of
antibiotic deposited, there was <0.5 and 0.8% of biomass
production and metabolic activity, respectively, for E. coli
biofilms grown on gentamicin coated plates. Using gentamicin-
plasma coated plates decreased P. aeruginosa metabolic activity
to <6% for all antibiotic layers tested, and completely inhibited
biomass production.
Bacterial Growth in the Presence of
Gentamicin-Plasma Coated Coupons
Plasma-deposited gentamicin on steel coupons was effective
at reducing the populations of planktonic cells of bacteria—
the antibiotic efficacy was retained after the plasma deposition
process and the antimicrobial effect was shortly apparent in the
surrounding liquid milieu of PBS or MHB.
Submerging gentamicin-coated coupons in PBS with a defined
bacterial load had an immediate antimicrobial effect. Populations
of E. coli and P. aeruginosa were reduced by 1.0 and 0.2 log10
CFU/ml (Figure 6), respectively in PBS, and by 0.7 and 1.7
log10 CFU/ml (Figure 7) in MHB. Within 4 h, 3.7 and 2.4 log10
CFU/ml reductions were achieved for E. coli and P. aeruginosa,
respectively in PBS. Cells of both strains were undetectable
from the media by 24 h (Figure 6). Antimicrobial efficacy of
gentamicin-coated coupons was more pronounced in MHB.
Within 4 h, 4.3 and 4.8 log10 CFU/ml reductions were achieved
for E. coli and P. aeruginosa, respectively. Complete inactivation
FIGURE 4 | Effect of plasma deposited antibiotics on micro-titer plates on
growth of planktonic E. coli and P. aeruginosa. (A,B) Growth of E. coli on
microtiter plates deposited with ampicillin and gentamicin, respectively. (C)
Growth of P. aeruginosa on microtiter plates deposited with gentamicin.
was achieved for E. coli and P. aeruginosa within 6 and 24 h,
respectively (Figure 7).
Elution of Gentamicin From Steel Coupons
Antibiotic detachment and elution into the surrounding liquid
was assessed to inform the stability and activity of plasma
coatings. Gentamicin-deposited coupons were submerged in
either PBS or MHB and the antimicrobial activity of aliquots of
the resulting solutions against both planktonic cells and bacterial
biofilms were tested over a period of 14 days.
Antimicrobial activity of PBS-gentamicin solution against
planktonic cells of E. coli remained unaffected for 2 days (< 1%
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FIGURE 5 | Biofilm formation of E. coli and P. aeruginosa on microtiter plates
coated with antibiotics: (A) total biomass and (B) cell viability. * indicates a
significant difference between the corresponding untreated control and
biofilms formed on microtiter plates coated with antibiotics (p < 0.05).
survivability) with a potential to be used for infection control
up to 7 days (< 25% survivability). PBS-gentamicin solution
incubated for 10 and 14 days resulted in a decrease of the
number of planktonic cells of E. coli by 20 and 30%, respectively.
Efficacy of PBS-gentamicin solution tested against P. aeruginosa
was stable for up to 7 days with <0.5% survival recorded. The
MHB-gentamicin solutions showed higher antimicrobial activity
than PBS-gentamicin solutions—with <0.5% cell survivability
for E. coli achieved up to 7 days, and <2% survival for solutions
incubated for both 10 and 14 days. Similarly, efficacy against P.
aeruginosa was retained for up to 14 days (< 1.5 % survivability).
Overall, MHB-gentamicin solution showed high activity both
against E. coli and P. aeruginosa for 14 days (Figure 8).
The potential for biofilm formation in the presence of
solutions containing gentamicin eluted from the steel coupons
into PBS and MHB was investigated. PBS solutions containing
eluted gentamicin inhibited biomass production when incubated
up to 2 days for E. coli (< 40% total biomass as compared
to control biofilms) and 1 day for P. aeruginosa (< 50%
total biomass). Using PBS-gentamicin solution eluted for 14
days promoted biomass production of P. aeruginosa. MHB-
gentamicin solutions inhibited biomass production of E. coli
by 80% up to 2 days and by 55–75% up to 14 days. MHB –
gentamicin eluted for 14 days inhibited 97% of P. aeruginosa
biomass production (Figure 9).
Stability of Gentamicin on Steel Coupons
During Dry Storage
A further interrogation of this process was to examine the
stability of plasma coated antibiotics on surfaces over time;
FIGURE 6 | Growth of planktonic cells of: (A) E. coli and (B) P. aeruginosa in
presence of plasma-treated steel coupons (control) and steel coupons
plasma-coated with gentamicin (ACP-G) submerged in PBS.
gentamicin deposited on steel coupons remained stable up to
3 weeks post plasma deposition, i.e., no growth after 24 h of
incubation was observed for planktonic cells of E. coli and P.
aeruginosa in the presence of gentamicin released into PBS and
MHB from the steel coupons stored for 3 weeks at 4◦C (data not
shown). Solutions were tested immediately upon submerging a
coupon into a liquid.
Changes of Surface Substrate
Characteristics After Plasma Deposition
It was observed that the surface of steel coupons subjected to
plasma deposition of antibiotics increased its hydrophilicity
which can be observed by a decrease of water contact
angle. After plasma deposition, water contact angle (WCA)
was decreased by ∼20% (Table 4). A reduction in the
WCA measurement was also detected on the coated
microplate samples, though the decrease was significantly
less pronounced than on the steel. This may reflect the
lower initial contact angle of the tissue culture microplate
(Table 5).
FTIR spectroscopy was also used to probe the chemistry
of the deposited materials. Coatings were deposited directly
onto sodium chloride discs using equivalent spray parameters.
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FIGURE 7 | Growth of planktonic cells of: (A) E. coli and (B) P. aeruginosa in
presence of plasma-treated steel coupons (Control) and steel coupons plasma
coated with gentamicin (ACP-G) submerged in MHB.
FIGURE 8 | Survivability percentage of planktonic cells of (A) E. coli and (B) P.
aeruginosa in presence of solutions containing gentamicin released from the
plasma coated steel coupons.
One coating was cured by powering on the plasma during
deposition and the second coating was cured by allowing the
wet solution to dry over a period of several hours. As shown
in Figure 10, both deposits produced equivalent spectra. Both
FIGURE 9 | Biofilm formation of (A) E. coli and (B) P. aeruginosa in presence
of solutions containing gentamicin eluted from the steel coupons over 14 days.
*indicates a significant difference between the corresponding untreated control
and biofilms formed in presence of solutions containing antibiotics (p < 0.05).
TABLE 4 | Effect of plasma deposition on water contact angle (WCA) and surface
free energy (γtot) values of steel coupons surface.
Sample WCA (◦) γtot [mN/m] Image
Control steel
coupon
96.4a ± 2.0 25.3a ± 1.2
Plasma-
coated
75.8b ± 3.6 38.1b ± 2.2
Different letters indicate significant difference between the control and plasma-coated
coupons (p <0.05).
spectra are dominated by the overlapping C-O stretches from
the multiple alcohol and ether groups between 1,000 and
1,080 cm−1 and a broad band from 3,000 to 3,600 cm−1 that
can be attributed to a combination of N-H stretches of the
amine groups and the O-H stretches from hydroxyl features.
Additional features include the C-H derived peak centered at
2,981 cm−1 and the N-H bends at 1,615 and 1,515 cm−1
in both spectra. a weak C-N stretch from the amine groups
can also be detected at 1,280 cm−1. No new features are
evident in the spectrum of the plasma treated sample and
there are no detectable peak shifts or alterations in intensity
when compared to the air dried sample. This indicates that the
plasma deposition process has not altered the chemistry of the
deposited antibiotic.
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TABLE 5 | Effect of plasma deposition on water contact angle (WCA) values of
polystyrene microplate surfaces.
Sample WCA (◦)
Control surface 58.3 ± 2.2
1 layer of plasma coating 57.2 ± 2.5
3 layers of plasma coating 59.3 ± 3.3
5 layers of plasma coating 54.7 ± 1.6
DISCUSSION
Despite aseptic precautions and antibiotic prophylaxis during
implantations, medical device-associated microbial infections
still remain a major public health concern and may have
serious consequences for the individual patient, including
removal of the implant and significant economic costs (Xu
et al., 2017). As systemic antibiotic treatment can be toxic to
organ systems and promote the spread of antibiotic resistance,
localized antimicrobial drug delivery is the subject of recent
efforts to combat biofilm formation and infection for both
preventive and treatment strategies (Jennings et al., 2015). The
advantages of localized antibiotic delivery at a specific site enables
administration of high local doses without exceeding the systemic
toxicity level of the drug and risking renal and liver complications
(Vasilev et al., 2011).
Antimicrobial coating of medical devices has emerged
as a potentially effective method to mitigate device-related
infections (Darouiche et al., 2007). Nikiforov et al. (2016)
advise that to obtain an active antimicrobial activity, an
antibiotic needs to be incorporated in the material surface. One
novel approach for engineering a new class of biomaterials is
using atmospheric pressure plasma processes for deposition of
antimicrobial compounds. In this study we demonstrated that
plasma deposition process can be used for a direct deposition
of pharmaceutical drugs on to a range of surfaces without loss
of functionality. To demonstrate this capability, two selected
antibiotics—ampicillin and gentamicin, were deposited onto two
types of surfaces—polystyrenemicrotiter plates and stainless steel
coupons. Through control experiments, it was established that
there was no separate antimicrobial or growth promoting effect
of the plasma deposition process, where there was no antibiotic
in the delivery stream. Therefore, plasma deposition process
did not enhance the antibiotic efficacy as studied, apart from
the flexibility offered through deposition on material surfaces.
Trentin et al. (2014) investigated the effect of N2/H2 plasma
surface modifications of polystyrene surface on growth and
adhesion of a range of multidrug resistant bacteria. It was
found that plasma treatments did not affect bacterial growth
on solid surfaces for any of the tested strains based on optical
density measurements, however, the exposure of polystyrene
surfaces to plasma had an effect on bacterial adhesion—the
treatment inhibited bacterial adhesion of strains that present
hydrophilic surface (hydrophobicity index below 70%), reaching
up to 83% adhesion inhibition for K. pneumoniae, 77% for S.
marcescens, 65% for S. aureus and 48% for E. cloacae, during
the first 24 h of incubation. Oppositely, S. epidermidis, which
present hydrophobic surfaces (hydrophobicity index above 70%),
retained its ability to adhere on the treated surfaces.
This study demonstrated that plasma deposition process
retained the antibiotic activity. The antibiotics deposited on
the test surfaces of microtiter plates retained good efficacy
against planktonic cells and prevented biofilm formation of
attached cells for up to 96 h (Figures 4, 5). Because of the
difficulty in quantifying the exact amount of antibiotic deposited
onto wells of a microtiter plate as a result of the deposition
process, we compared residual efficacy to that of a calibration
curve to provide an indication of the concentration range
achieved of the functional antibiotic deposited during the
process. Further chemical analysis is necessary to determine
this aspect in a fully quantitative manner, as well as confirm
structural retention post plasma deposition process. However,
initial spectroscopic analysis using FTIR suggests that there are
no detectable alterations in the chemical composition of the
deposited materials. This is in keeping with studies of other
biologics (Lackmann et al., 2018; Malinowski et al., 2018) that
show that short term exposures to low levels of cold helium
plasma as with the current deposition process investigated, had
no detectable effect on chemistry and structure.
Similarly, plasma-deposited gentamicin on steel coupons was
effective at reducing the populations of planktonic cells of
bacteria when eluted in the surrounding liquid environment
of both PBS and MHB (Figures 6, 7). The different types of
medium could influence the elution of gentamicin from the
coupons into the surrounding medium and/or affect the stability
of the antibiotic in the solution. Since mechanism of action
of gentamicin includes binding to the ribosomal subunit and
protein synthesis inhibition (Tangy, 1985), this could explain
why bacteria in PBS (not growing) are less affected - less
protein synthesis is required in this “stationary” state than in
actively dividing cells in MHB. Our preliminary tests showed
no biofilm formation on the coupons; due to a very high
antimicrobial activity of deposited gentamicin – after 24 h of
incubation time cells of both strains were undetectable and
biofilms could not be formed on gentamicin-coated coupons.
Therefore, in this study the effect of antibiotic-coated surfaces
on bacterial biofilm formation was tested only using microtiter
plates. According to Vasilev et al. (2011), a release coating should
provide fast initial release in the first 6 h after surgery to protect
the site, while the immune system is weakened, followed by
continuous “prophylactic” slow release. In our experiments it
was observed that submerging gentamicin-coated steel coupons
in either PBS or MHB liquids had an immediate antimicrobial
effect and complete inactivation was achieved for both E. coli
and P. aeruginosa within 24 h. Such rapid release of an entire or
significant amount of antibiotics from the tested surfaces when
in contact with liquids is not desirable as it can lead to negative
side effects, especially the increased risk of drug-induced toxicity.
Therefore, for the release in a controlled manner and prolonged
efficacy of antibiotics, they should be deposited inside the matrix,
which should be taken into consideration for future studies.
The elution of the antibiotic from the surface of gentamicin-
coated steel coupons into PBS and MHB and antimicrobial
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FIGURE 10 | FTIR Spectra of plasma deposited gentamicin coating (Top) and air dried gentamicin solution (Lower).
activity of the solutions against both planktonic cells and
bacterial biofilms was also investigated. Antimicrobial efficacy
of MHB-gentamicin solutions was higher than PBS-gentamicin
solutions—media formulation of MHB did not seem to impact
on the antibiotic stability or provide conditions for microbial
recovery and growth for up to 2 weeks duration. However,
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PBS is a more representative medium for potential future
applications concerning antibiotic deposition to medical device
and or implants. This proof of concept study was performed
to determine if the approach used was feasible and efficient,
therefore we employed a commonly used buffer solution
(PBS) in comparison to medium recommended for antibiotic
susceptibility testing by CLSI (MHB). The impact of more
complex media containing serum should be examined to probe
the degradation and chemical changes of antibiotics in a medium
reflecting more realistic and challenging clinical conditions.
The surface of steel coupons subjected to plasma deposition
of antibiotics increased in hydrophilicity; observed through
a decrease of WCA by ∼20% (Table 4). It is probable
that an increase of hydrophilic properties can be used to
achieve a better biomolecule adsorption on the surface
and enhanced interactions with aqueous environment,
enabling the active compound to be fully released to the
surrounding solution. Plasma treatment has been previously
reported to modify both stainless steel (Kim et al., 2003)
and polystyrene surfaces (Mitchell et al., 2004) to be
more hydrophilic.
In the future experiments the approach described in this
study needs to be tested against Gram-positive bacteria, especially
Staphylococcus aureus, frequently associated with medical-device
related infections. For the present study, Gram-negative bacteria
were selected, as generally they are more resistant to antibiotic
treatment than Gram-positive. Selected E. coli and P. aeruginosa
have higher MIC quality control ranges of gentamicin (0.25–1
and 0.5–2, respectively) as compared to Staphylococcus aureus
(0.12–1) (CLSI, 2015). Although the results of this study
demonstrate the retained efficacy against planktonic cells and
prevented biofilm formation of attached cells on the test
surfaces after plasma deposition of antibiotics, further work
is necessary to determine if this approach can reduce the
rate of implant-associated infections for both in vivo and in
clinical applications.
CONCLUSION
Overall, a novel plasma process for direct deposition of
active pharmaceutics showed retention of antimicrobial effect
and efficacy of the antibiotic-coated surfaces against E. coli
and P. aeruginosa. Direct plasma deposition of antimicrobial
compounds shows potential to functionalize a surface to
prevent or control device associated infection. This presents an
alternative to systemic antibiotic delivery that can be localized to
a surgical or implant site and employs only the active antibiotic
delivery stream. No independent antimicrobial or microbial
growth promoting effects of the plasma deposition process
were observed.
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